Brian Lian
Chief Executive Officer, Viking Therapeutics.
Companies
- Viking TherapeuticsBoard member Apr 28, 2015 to now1
- Viking TherapeuticsChief executive officer Apr 28, 2015 to now1
- Viking TherapeuticsPresident Apr 28, 2015 to now1
- Apricus BiosciencesBoard member Jan 28, 2019 to Jan 8, 20242
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Viking Therapeutics VKTX2,572,441 shares3$64.6M at $25.11Jul 29, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 29, 2026Sold 148,517 shares at $33.32 of Viking Therapeutics3
- Jul 28, 2026Granted 221,667 shares of Viking Therapeutics3
- Jan 5, 2026Sold 6,400 shares at $35.07 of Viking Therapeutics4
- Jan 5, 2026Sold 41,276 shares at $34.22 of Viking Therapeutics4
- Jan 5, 2026Sold 53,279 shares at $33.38 of Viking Therapeutics4
- Jan 5, 2026Sold 132,454 shares at $32.29 of Viking Therapeutics4
- Jan 2, 2026Granted 224,080 shares of Viking Therapeutics4
- Jan 2, 2026Granted 78,400 shares of Viking Therapeutics4
- Oct 28, 2025Sold 38,989 shares at $35.01 of Viking Therapeutics5
- Oct 27, 2025Granted 70,084 shares of Viking Therapeutics5
- Jul 3, 2025Sold 26,889 shares at $27.80 of Viking Therapeutics6
- Jul 2, 2025Granted 48,333 shares of Viking Therapeutics6
- Jan 6, 2025Sold 19,000 shares at $43.32 of Viking Therapeutics7
- Jan 6, 2025Sold 175,490 shares at $42.68 of Viking Therapeutics7
- Jan 3, 2025Granted 163,333 shares of Viking Therapeutics7
- Jan 3, 2025Granted 92,800 shares of Viking Therapeutics7
- Sep 20, 2024Sold 200 shares at $71.99 of Viking Therapeutics8
- Sep 20, 2024Sold 119,874 shares at $71.15 of Viking Therapeutics8
- Sep 20, 2024Sold 96,056 shares at $70.43 of Viking Therapeutics8
- Sep 20, 2024Exercised options 166,130 shares at $7.77 of Viking Therapeutics8
- Aug 21, 2024Sold 1,000 shares at $69.90 of Viking Therapeutics9
- Aug 21, 2024Exercised options 1,000 shares at $7.77 of Viking Therapeutics9
- Aug 19, 2024Sold 11,296 shares at $67.12 of Viking Therapeutics10
- Aug 19, 2024Sold 31,442 shares at $66.37 of Viking Therapeutics10
- Aug 19, 2024Sold 70,132 shares at $65.33 of Viking Therapeutics10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARViking Therapeutics, Board member
- 2SEC EDGARApricus Biosciences, Board member
- 3
- 4SEC EDGARForm 4 filed Jan 5, 2026
- 5SEC EDGARForm 4 filed Oct 28, 2025
- 6SEC EDGARForm 4 filed Jul 3, 2025
- 7SEC EDGARForm 4 filed Jan 6, 2025
- 8SEC EDGARForm 4 filed Sep 20, 2024
- 9SEC EDGARForm 4 filed Aug 22, 2024
- 10SEC EDGARForm 4 filed Aug 19, 2024